MODERNA

The Food and Drug Administration's independent advisory committee on Thursday unanimously recommended replacing Pfizer and Moderna's original Covid vaccine used in the U.S. for everyone's first two immunizations with the new bivalent omicron shots. Instead, the drugmakers' bivalent omicron shots that target the omicron BA.5 subvariant as well as the original strain would be used for the entire vaccination series. Currently, Pfizer's and Moderna's omicron shots are only authorized as a booster, while the first two doses are still their old shots based on the original Covid strain. The FDA has proposed moving to a system that resembles how the agency updates and rolls out flu shots every year. The agency would select a Covid vaccine formulation in June to target the variant that is expected to dominate in the fall and winter.

Greedy pharma firms rip off Americans while Pfizer, Moderna swim in profits. 5 firms totaled $80 billion in profits, but millions can’t afford medicine.

These are the stocks posting the largest moves before the bell.

RSV infections kill between 6,000 and 10,000 older adults every year and result in 60,000 to 120,000 hospitalizations, according to the CDC.

Sanders, the incoming chair of the Senate health committee, called the price increase "outrageous" in a letter to Moderna CEO Stephane Bancel.

These are the stocks posting the largest moves in midday trading.

The stocks making the biggest moves in premarket trading include Oracle, Boeing, Moderna, and more.

The FDA on Thursday approved the use of updated COVID-19 vaccines for children younger than 5, three days after Pfizer-BioNTech applied for an emergency use authorization.

Pfizer asked a federal court in Boston on Monday to dismiss Moderna's lawsuit seeking monetary damages for alleged patent violations related to the Covid vaccine.

Moderna found that the new booster triggered five times more antibodies against omicron BA.5 than the old vaccines in people with prior Covid infections.

Moderna also missed revenue and earnings expectations for the quarter.

Double the spike proteins may not mean double the fevers and chills.

Novavax's Covid shots rely on protein technology used in other vaccines for decades, rather than the messenger RNA used in the Pfizer and Moderna vaccines.

These are the stocks posting the largest moves midday.

Tweaked boosters rolled out for Americans 12 and older last month, modified to target today's most common and contagious variant. The latest move may expand protection before an expected winter wave.

Moderna's vaccine is being studied in combination with Merck's Keytruda to treat patients with high-risk melanoma, the deadliest form skin cancer.

U.S. stock futures bounce as bond yields fall on the first trading day of October and the final quarter of a terrible 2022.

Americans have two options for getting a new omicron-specific Covid booster shot: Pfizer or Moderna. Which one should you get? Here's what experts say.

Moderna has asked the FDA to authorize omicron boosters for adolescents ages 12 to 17-years-old and for kids ages 6 to 11-years-old.

Providers have reported delays in shipments of Moderna's new shots, which make up some 20% of doses around the country.

Reconfigured shots are safe, but had been delayed amid inspection of an Indiana packaging plant last month.

Outgoing Wyoming Rep. Liz Cheney (R) revealed that many in her own party hold their nose and support Trump, for fear of getting punished at the ballot box.

The Center for Disease Control and Prevention is recommending an additional COVID-19 booster shot that targets the Omicron variant.

Newly updated Covid vaccine booster shots designed to target omicron's BA.5 subvariant are finally here. Here's how — and where — you can find them.

Pfizer and Moderna have released a new COVID booster shot that will target the highly contagious BA.4 and BA.5 omicron variant.

The number of new coronavirus cases and deaths reported globally continued to fall nearly everywhere in the world in what the World Health Organization described as a “welcome decline” at a media briefing on Wednesday.

The new shots from Moderna and Pfizer-BioNTech target both the original strain of the coronavirus and the omicron BA.4/BA.5 subvariants that most people are catching now.

U.S. regulators have authorized updated COVID-19 boosters, the first to directly target today's most common omicron strain.

These are the stocks posting the largest moves before the bell.

The pending arrival of an Omicron booster shot marks an ambitious new phase in the nation's vaccination campaign before a possible new COVID surge.

Good afternoon, Chicago. Here's what is happening today.

If the long legal tangles around Crispr are any guide, innovation in this promising technology will continue.

The vaccine maker alleges that its rivals Pfizer and BioNTech used some patented features of its mRNA technology to develop their COVID vaccines.

Moderna said it is suing Pfizer and its German partner BioNTech for patent infringement.

The lawsuit sets up clash between rival vaccine makers who used novel mRNA technology to speed delivery of shots.

COVID-19 vaccines tweaked to better match today’s omicron threat are expected to roll out in a few weeks but how much will they help.

The trials began Thursday and are expected to finish within the next few days.

The U.N. health agency said there were 5.4 million new COVID-19 cases reported last week, a decline of 24% from the previous week.

The U.N. health agency said there were 5.4 million new COVID-19 cases reported last week, a decline of 24% from the previous week.

The U.N. health agency said there were 5.4 million new COVID-19 cases reported last week, a decline of 24% from the previous week.

New coronavirus cases reported globally in the last week dropped by nearly a quarter while deaths fell by 6%

New coronavirus cases reported globally in the last week dropped by nearly a quarter while deaths fell by 6%.

In the U.S., officials have asked vaccine makers to target BA.5, rather than the original omicron strain. That has delayed the boosters' development — but officials hope they will be more effective.

The coronavirus shots were also effective against the omicron subvariants BA.4 and BA.5 in clinical trials, U.K. health authorities said.

A Covid jab that targets two strains of Covid in a world-first leads Tuesday's headlines.

Britain on Monday became the first country in the world to approve a dual Covid-19 vaccine, which tackles both the original virus and the newer Omicron variant.

British health authorities have authorized an updated version of Moderna’s coronavirus vaccine that aims to protect against the original virus and the omicron variant

British drug regulators have become the first in the world to authorize an updated version of Moderna’s coronavirus vaccine that includes protection against the omicron variant, which the government said would now be offered to people aged 50 and over in the fall.

British drug regulators have become the first in the world to authorize an updated version of Moderna's coronavirus vaccine that aims to protect against the original virus and the omicron variant. In a statement on Monday, the Medicines and Healthcare Regulatory Agency said it had given the green light to Moderna's combination “bivalent” vaccine, which will be used as an adult booster shot. Each dose of the booster shot will target both the original COVID-19 virus that was first detected in 2020 and the omicron BA.1 variant that was first picked up in November.

Moderna took a nearly $500 million hit on write-downs for vaccine inventory that has expired or is expected to expire before is can be used.

The stocks making the biggest moves in premarket trading include CVS, Under Armour, Moderna and more.

Many scientists believe that updating the vaccines to target omicron BA.4 and BA.5 will provide more durable protection against infection this fall.

With new COVID-19 boosters expected later this year, health experts urge Californians not to put off a first or second booster shot until then.

Canadian regulators have authorized Moderna’s COVID-19 shots for infants and preschoolers

Vaccinating children under 5 is crucially important in the country's fight against Covid, experts say. Just don't expect the virus to disappear overnight.

A court ruling is back in effect that blocks President Joe Biden from requiring federal employees to get vaccinated against COVID-19.

The U.S. Food and Drug Administration is considering ordering a recipe change for the vaccines made by both Pfizer and rival Moderna in hopes that modified boosters could better protect against another surge.

Pfizer's Omicron-only booster sparked the strongest immune response against that variant.

Pfizer says tweaking its COVID-19 vaccine to better target the omicron variant is safe and boosts protection.

The White House COVID-19 response team is urging parents to get their young children vaccinated as the country begins to rollout vaccines to the youngest population.

Will you be vaccinating your child?

The nation’s youngest children are getting their chance at vaccines for COVID-19.

U.S. health officials have opened COVID-19 vaccines for infants, toddlers and preschoolers — the last group without the shots.

U.S. regulators have authorized the first COVID-19 shots for infants and preschoolers.

A government advisory panel has endorsed a second brand of COVID-19 vaccine for school-age children and teens.

Next week brings a marathon of hearings as the U.S. decides whether to open COVID-19 vaccinations to kids under 5.

Now that an FDA advisory committee has recommended the Novavax COVID-19 vaccination for emergency use, experts say we could possibly see the FDA give full approval of the vaccine soon.

Moderna says its experimental COVID-19 vaccine that combines its original shot with protection against the omicron variant appears to work.

Parents hoping to get their youngest children vaccinated against COVID-19 have some encouraging news.

U.S. regulators are strictly limiting who can receive Johnson & Johnson’s COVID-19 vaccine due to a rare but serious risk of blood clots.

Pfizer now hopes to tell U.S. regulators how well its COVID-19 vaccine works in the littlest kids by early June.

The Food and Drug Administration has set tentative dates in June to publicly review COVID-19 vaccines for the youngest American children.

Moderna is asking U.S. regulators to open its COVID-19 vaccine to the nation's youngest children.

Moderna is asking U.S. regulators to open its COVID-19 vaccine to the nation's youngest children.

Many Americans can now get a second COVID-19 booster, but it’s hard to tell who really needs another shot right now and who could wait.

The Food and Drug Administration on Tuesday authorized another COVID-19 booster for people age 50 and older.

Americans age 50 and older can get a second COVID-19 booster if it’s been at least four months since their last vaccination.

Moderna says it will ask regulators to authorize its COVID-19 vaccine for children under 6 but several hurdles need to be cleared before the shots could become available.

Moderna says its COVID-19 vaccine works in babies, toddlers and preschoolers.

Drugmaker Moderna has asked the Food and Drug Administration to authorize a fourth shot of its COVID-19 vaccine as a booster dose for all adults.

The World Health Organization is creating a global training center to help poorer countries make vaccines, antibodies and cancer treatments using the messenger RNA technology used to make COVID-19 vaccines.

Egypt, Kenya, Nigeria, Senegal, South Africa and Tunisia will be the first African countries to receive the technology required to produce mRNA vaccines on the continent.

Tokyo has launched a mass inoculation drive for COVID-19 booster shots at a temporary center operated by the military as Japan tries to speed up delayed third jabs to counter surging infections.

Moderna has begun testing an omicron-specific version of its COVID-19 vaccine in healthy adults.

Haiti's health minister says the country is fighting a rise in COVID-19 cases as the government struggles to convince people to get vaccinated.

U.S. officials are loosening rules that call on health care workers to stay out of work for 10 days if they test positive for COVID-19.

As Americans get ready for the holidays, COVID-19 cases are surging in parts of the United States.

Moderna said Monday that a booster dose of its COVID-19 vaccine should offer protection against the rapidly spreading omicron variant.

U.S. health officials say most Americans should get the Pfizer or Moderna vaccines instead of the Johnson & Johnson shot.

Vaccine makers are racing to update their COVID-19 shots against omicron even before it’s clear a change is needed, just in case.

New York City instituted a new mask mandate Tuesday as the stock market was down over renewed COVID fears.

Asian shares are mixed as investors continue to cautiously weigh how much damage the new omicron coronavirus variant may unleash on the global economy.

The U.S. is opening COVID-19 vaccine boosters to all adults, and urging them for anyone 50 and older.

The NBA has told its players, coaches and referees that they should receive booster shots against the coronavirus, with particular urgency for those who received the single-dose Johnson & Johnson vaccine.

The city of Jacksonville, in partnership with Agape Family Health and the Florida Department of Health in Duval County, on Thursday announced additional COVID-19 vaccination services at four city-funded locations.

Moderna is scaling back expectations for the number of COVID-19 vaccine deliveries it expects to make this year and the revenue it will record from them.

Moderna says it will make up to 110 million doses of its COVID-19 vaccine available to African countries.

Moderna says its low-dose COVID-19 vaccine is safe and appears to work in 6- to 11-year-olds.

Georgia officials say local health departments will begin offering more COVID-19 vaccine booster shots on Tuesday, following guidance from the U.S. Centers for Disease Control and Prevention.

A team of young scientists in South Africa is assembling the equipment needed to reverse engineer Moderna's coronavirus vaccine.